Neuro Salt

NeuroSalt is a South Korean biotechnology company focused on developing treatments for neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease. The company's core technology involves the development of specialized salt-based small molecule therapeutics designed to modulate neuronal activity and reduce neuroinflammation. Their lead candidate, NS-001, is being investigated for its potential to improve cognitive function and slow disease progression in dementia patients. Founded by experts in neuroscience, NeuroSalt aims to provide novel therapeutic options by targeting ion balance and glial cell function in the brain. The company is currently advancing its pipeline through preclinical studies and early-stage clinical planning to address significant unmet needs in the central nervous system space.